The comparison of baseline parameters and assisted reproductive outcomes between the two groups showed that serum AMH levels decreased significantly and clinical pregnancy outcomes were poorer in the T2DM group, which demonstrated that T2DM adversely affects ovarian reserve and assisted reproductive outcomes. The gene discussed is AMH; the disease is type 2 diabetes mellitus.